A Phase I study that evaluated whether a gel containing dapivirine is safe for use in the rectum. The study will help determine whether further testing on the safety and acceptability of dapivirine gel as a potential rectal microbicide can be conducted in a larger population. Results are anticipated in late 2019.
30-October-2017
30-October-2017
See Also
Rectal Microbicides - Fact Sheet
17-July-2018